Abstract:Key PointsNitric oxide (NO) is a gaseous signalling molecule that is involved in the regulation of the cardiovascular, immune and nervous systems.In the CNS, NO is involved in many processes, including the regulation of synaptic plasticity, the sleep–wake cycle, neurosecretion, fluid balance and reproductive processes. In the PNS, NO is an inhibitory neurotransmitter that mediates the non-adrenergic, non-cholinergic relaxation of smooth muscle in both the gastrointestinal and urogenital tracts.NO exerts its effect on an array of functions through the activation of several intracellular signalling pathways. One key pathway is the soluble guanylyl cyclase–cyclic GMP–protein kinase G system.Physiological amounts of NO are neuroprotective, owing to S-nitrosylation of NMDA (N-methyl-D-aspartate) receptor subunits or of the active sites of caspases. Furthermore, NO activates Akt and CREB (cyclic AMP-responsive-element-binding protein), which are involved in two important survival pathways. NO also induces haem oxygenase 1, a key enzyme in the cellular stress response.If it is produced in excess, or if a cell is under conditions of oxidative stress, NO becomes noxious and may undergo an oxidative–reductive reaction to form toxic compounds known as reactive nitrogen species (RNS), which cause cell damage. Both NO and RNS have a pathogenetic role in the onset and development of neurodegenerative disorders.Although drugs that act on the NO–cGMP pathway are commonly used to treat impotence, lung diseases and pulmonary hypertension, their use for the prevention of neurodegenerative disorders is unlikely. The use of natural antioxidants, such as polyphenols, has been proposed for the prevention or treatment of Alzheimer's disease because of their in vitro ability to counteract NO-induced damage. However, the pharmacokinetics of these substances may limit their use in humans, and so more effort would be required to make these natural substances efficient in the treatment of neurodegenerative disorders.

Serologic classification of chimpanzee adenoviruses by hemagglutination and hemagglutination inhibition.

Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential

Recent advances on the roles of NO in cancer and chronic inflammatory disorders

Characterization of the Role of Nitric Oxide and Its Clinical Applications

[Optimization of kidney transplantation from elderly donors].

Physiological Roles of Nitrite and Nitric Oxide in Bacteria: Similar Consequences from Distinct Cell Targets, Protection, and Sensing Systems

Nitric oxide-dependent endothelial function and cardiovascular disease

Regulation of Vascular Function by Nitric Oxide-Related S-nitrosylation

The Emerging Role of GSNOR in Oxidative Stress Regulation

Harnessing polyphenol power by targeting eNOS for vascular diseases

Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity

Nitric Oxide Signaling and Sensing in Age-Related Diseases

Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation

Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases.

Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia.

Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases

Nitric Oxide Synthases in Cyanobacteria: Diversity, Cellular Implications and Ecological Pertinence

Nitric Oxide Binding Geometry in Heme-Proteins: Relevance for Signal Transduction

Recent Advancements in Polymeric N-Nitrosamine-Based Nitric Oxide (NO) Donors and their Therapeutic Applications

Dietary nitrate biochemistry and physiology. An update on clinical benefits and mechanisms of action

Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis